Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M2i Life Sciences specializes in the research, development, and manufacturing of fine chemicals—including active pharmaceutical ingredients—and pheromone-based biocontrol solutions. The company operates as a CDMO/CRO for custom synthesis projects in human and animal health. It has a strong commercial presence in Europe with a focus on sustainable alternatives to traditional chemical treatments in agriculture and public health. Its pharma division produces APIs under GMP conditions but does not appear to have its own clinical pipeline of novel therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M2i Life Sciences.